Electronic Health Record Interoperability

Electronic health record (EHR) interoperability is the ability of disparate health information systems to exchange, interpret, and use data across organizational and technical boundaries without loss of meaning. It is the foundational precondition for seamless care coordination, clinical decision support, and secondary use of real-world clinical data.

Also Called / Synonyms

EHR interoperability, health data interoperability, health information exchange (HIE) capability, system integration, semantic data exchange. These terms are often used interchangeably but carry subtle differences: HIE typically refers to the act of sharing data, while interoperability denotes the systems' capacity to do so meaningfully.

Interoperability Levels & Key Terms

Four progressive levels are recognized in both technical and clinical discourse, each building on the last:

Why Interoperability Matters

Unstructured clinical text remains a major barrier to interoperable data reuse ^[7]C4. When interoperability fails, patient safety incidents, such as delayed imaging reports affecting high-risk patients, increase sharply, as seen in a 2026 analysis of an EHR go-live where serious radiology-related incidents rose from 1 to 12 after implementation, with 11 directly attributable to integration gaps ^[8]B2b. Conversely, robust interoperability reduces redundant testing, improves chronic disease management , and powers learning health systems. These clinical outcomes are the subject of the next section.

Pearl: True interoperability requires all four levels, technical connectivity alone (foundational) without semantic agreement can worsen harm by exchanging data that systems misinterpret. Always verify a system's highest achieved interoperability level before trusting cross-EMR data.

Interoperability transforms clinical outcomes by directly addressing the data fragmentation that undermines care coordination, medication safety, diagnostic accuracy, and population health. Without seamless exchange of patient information across systems, clinicians operate with incomplete data, leading to delays, errors, and inefficiencies ^[8]B2b[12]D5.

Care Coordination and Continuity

Interoperability enables a single, shared view of the patient across settings, primary care, hospital, specialty, and home. Electronic problem lists , when accurate and current, serve as the backbone of longitudinal care and are foundational for clinical decision support ^[2]B2a. Yet, fragmented technical systems burden family physicians with excessive inbox tasks, contributing to burnout and inadvertently leading to uninformed clinical decisions ^[11]B2a. When interoperability is functional, electronic patient-reported outcomes (ePROs) can be integrated into workflows, improving symptom control, quality of life, and reducing emergency visits and hospitalizations ^[15]D5. The American College of Medical Informatics fellows identified data sharing and interoperability as critical to “getting the right care” and guiding low-cost evaluations ^[17]D5.

Medication Safety

Complete medication histories across all care sites reduce the risk of adverse drug events. Integrated EHR and automated compounding systems for parenteral nutrition demonstrate how interoperability, combined with clinical decision support, optimizes prescription accuracy through real-time alerts and dose limits ^[16]D5. However, when systems fail to communicate, as during go-live transitions, serious delays in reporting affect high-risk patients, and information flow problems lead to missing medication data ^[8]B2b. Clinicians struggle to locate critical information buried in unstructured notes, increasing the potential for prescribing errors ^[12]D5. Interoperable systems with structured medication reconciliation tools directly mitigate these risks.

Diagnostic Accuracy

Diagnostic decisions depend on access to prior test results, imaging, and clinical notes. In rural hospitals lacking on-site infectious disease specialists, an interoperable EHR alert providing first-line guidance on urgency, therapy, and communication supports guideline-concordant care for Staphylococcus aureus bacteremia ^[18]C4. Conversely, fragmented data forces clinicians to make decisions without full context, a problem highlighted in family medicine where duplicated or unnecessary tasks and uninformed clinical decisions arise from poor data sharing ^[11]B2a. Unstructured data entry degrades the ability to extract reliable clinical information for decision support ^[12]D5. Interoperability ensures that relevant data are structured and accessible, reducing diagnostic errors.

Public Health and Population Health

The secondary use of interoperable EHR data has evolved over 25 years to become central to public health surveillance, real-world evidence generation, and quality measurement ^[13]D5. Oncology care exemplifies the need: precise, structured documentation of staging and treatment changes enables trial matching and real-world evidence that would be impossible with unstructured notes ^[12]D5. ePRO integration further supports population health management by aggregating patient-reported outcomes across cohorts ^[15]D5. Interoperability transforms fragmented data into a resource for improving care at scale.

Table 1 summarizes the key clinical benefits across these domains.

Table 1. Clinical Benefits of EHR Interoperability by Domain

Each domain relies on underlying standards and architectures, which are discussed in the next section.

Pearl: Interoperability is the infrastructure that prevents critical clinical information from being lost across care transitions; without it, even the most sophisticated EHR can paradoxically increase patient risk by fragmenting data rather than unifying it.

The clinical benefits of interoperability outlined above depend on a set of technical standards that enable different health information systems to exchange, interpret, and use data reliably. This section reviews the principal standards, including HL7 FHIR, common data models (CDMs), terminology systems, and emerging frameworks, and the evidence for their current adoption, strengths, and limitations.

HL7 FHIR: The Leading Standard for Real-Time Exchange

HL7 Fast Healthcare Interoperability Resources (FHIR) has emerged as the dominant standard for real-time data exchange, combining modern web technologies (RESTful APIs, JSON/XML) with a modular resource-based design. Among three major health data standards, FHIR was used in 39% of reviewed implementation studies, second only to OMOP-CDM (57%) and well ahead of openEHR (8%) ^[20]B2a. FHIR dominates in public health domains and for real-time exchange, while OMOP-CDM is preferred for large-scale longitudinal research ^[20]B2a.

Adoption and maturity. In a survey of organizations participating in PCORnet®, 73% (49 of 67) reported that FHIR was deployed in a production capacity ^[31]D5. However, the quality of FHIR-based data extracts varied: when compared with PCORnet® CDM extracts, Cohen kappa ranged from 0.01 to 0.76 for diagnoses, 0.24 to 0.84 for laboratory results, and 0.1 to 0.87 for medications, indicating that FHIR extracts may be suitable for some study designs but not all ^[31]D5. A proof-of-concept project for the American College of Cardiology CathPCI Registry found that only 32% (111/344) of registry data concepts were sufficiently discrete and terminologically mapped for direct FHIR provisioning; the remainder required manual abstraction ^[27]D5.

Implementation challenges. FHIR implementations often require customization, which complicates interoperability ^[20]B2a. Customization may involve extending profiles, adding extensions, and mapping local vocabularies. For example, while a FHIR Implementation Guide for wearable device data (lifestyle medicine) comprised 74 profiles, 50 extensions, and 546 artifacts, a two-phase terminology audit found that 718 of 1173 custom codes had no standard equivalents in LOINC or SNOMED CT ^[10]C4. Core heart rate variability metrics such as RMSSD and pNN50 remain uncoded ^[10]C4. Such gaps highlight the need for ongoing terminology development and the use of "semantic convergence buffers" (intermediary CodeSystems with ConceptMap coverage to LOINC, SNOMED CT, and OMOP) ^[10]C4.

Consent and governance. The FHIR Consent resource provides an interoperable representation of authorization intent, but large-scale deployments are limited by non-canonical semantics, lack of standardized lifecycle versioning, and heterogeneous translation of consent into access control ^[26]D5. An architecture that separates consent representation (FHIR Consent), local policy enforcement, and cross-organizational integrity verification (e.g., cryptographic anchoring) has been proposed ^[26]D5. Integrating FHIR with blockchain has shown promise for patient-controlled consent management ; the WiraChain platform demonstrated reliable permission granting/revocation and role-based access control under simulated clinical workflows ^[29]D5.

Common Data Models: OMOP-CDM, PCORnet CDM, and openEHR

Common data models (CDMs) harmonize data from disparate sources into a shared schema, enabling federated analysis. The most popular CDMs are OMOP-CDM (Observational Medical Outcomes Partnership), PCORnet CDM, i2b2, and Sentinel CDM. In a systematic evaluation, OMOP CDM and FHIR scored best overall across criteria of suitability, popularity, adaptability, interoperability, and support ^[21]B2a.

Data quality concerns. A study within the German Medical Informatics Initiative found that the FAIRification process (converting raw data to FHIR) introduced numerous completeness issues: out of 1988 distinct data quality issues identified, 1977 were completeness issues induced by the transformation ^[28]D5. Importantly, 68% of all issues were resolvable, underscoring the need for dedicated data quality assessments ^[28]D5.

Terminology Standards: Mapping Clinical Concepts

Semantic interoperability requires consistent representation of clinical concepts. The most important terminology standards are:

• LOINC (Logical Observation Identifiers Names and Codes): Standardizes laboratory tests, observations, and measurements. A biomedical NLP approach (ScispaCy-LOINC) achieved the highest coverage on noisy data (MIMIC-IV), correctly identifying the LOINC code in 42.3% of cases, outperforming keyword-based (19.5%) and semantic search (21.4%) algorithms ^[30]D5. However, on more standardized data (CIEL terminology), semantic search performed best (54.4%) ^[30]D5. This highlights complementary strengths and the need for hybrid mapping tools ^[30]D5.
• SNOMED CT: Provides comprehensive clinical terminology for diagnoses, procedures, and findings. Gaps remain in wearable device metrics (e.g., HRV metrics) and rare disease coding ^[10]C4[28]D5.
• ICD (International Classification of Diseases): Widely used for morbidity and mortality coding, but insufficient granularity for many research use cases (especially rare diseases) ^[28]D5.
• ICF (International Classification of Functioning, Disability and Health): Being integrated into the European Health Data Space (EHDS) for documenting functioning in patient summaries and discharge reports. Many EU countries lack standardized EHR support for structured ICF data; a three-phase roadmap (awareness, technical integration via FHIR, policy alignment) has been proposed ^[22]D5.

Emerging Frameworks: Blockchain, LLMs, and Zero-Trust Architecture

Blockchain has been proposed to enhance auditability, access control, and technical communication in EHR systems, particularly when integrated with FHIR ^[19]B2a. In a systematic review of 16 empirical studies (primarily prototypes), blockchain-based systems showed improvements in security and interoperability outcome measures, though definitions of "interoperability" varied (e.g., exchange success rate, API response time, standards compliance) ^[19]B2a. Performance and scalability constraints (latency vs. throughput trade-offs), governance conflicts (GDPR "right to erasure" vs. immutable ledgers), and key management remain significant barriers ^[19]B2a.

Large language models (LLMs) offer a pathway to extract structured data from unstructured clinical text for FHIR mapping. A fine-tuned 27-billion-parameter model (MedGemma 27B) trained on synthetic discharge letters (n=75,000) achieved F1-scores of 0.84 for ICD codes, 0.99 for laboratory values, and 0.94 for medication codes on synthetic test sets ^[7]C4. When evaluated on 30 real-world discharge letters, case-level correctness was 78.9% for diagnoses, 93.0% for medications, but only 61.3% for procedures ^[7]C4. This demonstrates potential but the need for further refinement.

Zero-trust architecture combined with FHIR has been validated in a microservice framework achieving sub-100 ms processing latency, with security controls blocking credential replay, SQL injection, and horizontal privilege escalation ^[25]C4. Such architectures align with EHDS regulation and support real-time analytics ^[25]C4.

Choosing a Standard: Context-Dependent

No single standard meets all needs. A systematic review concluded: "Given the unique characteristics, strengths, and weaknesses of each CDM and data standard, no single global representation can be selected" ^[21]B2a. Hybrid approaches, using FHIR for exchange, OMOP-CDM for analytics, and openEHR for data persistence, appear most promising ^[20]B2a. The next section builds on this foundation by examining the technical infrastructure and architectures required to implement these standards at scale.

Pearl: The choice of interoperability standard should be driven by the primary use case: FHIR for real-time data exchange and public health, OMOP-CDM for large-scale observational research, and openEHR for comprehensive clinical data persistence. Terminology gaps remain for wearables and rare diseases, always verify that your standard covers the required concepts before deployment ^[10]C4[28]D5.

Building on the standards layer, the technical infrastructure that enables EHR interoperability rests on three architectural axes: data storage topology, API design, and terminology mapping pipelines. Each axis involves trade-offs between control, scalability, and semantic fidelity.

Centralized, Federated, and Hybrid Models

Health information exchange (HIE) architectures fall along a spectrum from fully centralized repositories to fully distributed query models. In a centralized model, all participating organizations send data to a single repository, which is then accessed by authorized providers. This topology simplifies query logic and ensures a consistent view of patient data, but creates a single point of failure, raises privacy concerns, and often struggles with data-latency for real-time use. Federated models keep data at the source and route queries across nodes; the requesting system retrieves results without moving the entire record. Federated architectures better align with organizational data governance but introduce network latency, schema-mapping complexity, and reliance on robust query standards. Hybrid models, the most common in large-scale national implementations, combine a lightweight central index or patient-locator service with federated retrieval for detailed data.

The choice of topology directly affects implementation outcomes. In a systematic review of HIE implementation studies, adoption was the most frequently reported outcome (reported in 24 of 37 studies), while fidelity and penetration were never reported ^[33]D5. This suggests that architectural choices are rarely evaluated against the fidelity of data exchange, leaving gaps in evidence for which model best supports sustained interoperability.

API-Based Approaches and Vendor-Agnostic Design

Application Programming Interfaces (APIs), especially RESTful FHIR APIs, have become the dominant mechanism for real-time data exchange. The FHIR REST API allows systems to query, create, update, and delete resources using standard HTTP methods. Large language models (LLMs) evaluated on FHIR knowledge achieved high accuracy on REST API questions: GPT-4o scored 0.9267 F1 on the FHIR-RESTQA task, and DeepSeek-V3 scored 0.9400 ^[35]D5. However, converting unstructured clinical text into FHIR-compliant resources (the Note2FHIR task) remains a major challenge: maximum performance was 0.3633 F1 (GPT-4.5-preview), highlighting that unstructured-to-structured conversion is the most brittle link in API-driven workflows ^[35]D5.

Governance at the national level should promote common APIs across implementations ^[32]D5. Vendor-agnostic API specifications allow third parties to query a service using a patient identifier and medicine code, enabling services such as pharmacogenomic-guided prescribing to be deployed "as-a-service" and integrated with existing clinical decision support tools within the native EHR ^[37]D5. The key insight is that data should be separated from applications, a principle that enables the same API to serve different EHRs without custom integration ^[37]D5.

Terminology Mapping and Automated Code Alignment

Even with standardized APIs, semantic interoperability fails when the same laboratory test or clinical concept is encoded differently across systems. Automated mapping of local laboratory strings to LOINC (Logical Observation Identifiers Names and Codes) is a critical infrastructure component. A ScispaCy-based natural language processing pipeline (ScispaCy-LOINC) correctly identified the LOINC code in 42.3% of MIMIC-IV laboratory items, compared to 19.5% for Elasticsearch Keyword Retrieval and 21.4% for MiniLM Semantic Search ^[30]D5. In more standardized datasets (CIEL), the semantic search approach performed best (54.4%), demonstrating that no single algorithm dominates across all data quality profiles ^[30]D5. The complementary strengths of algorithmic methods support an integrated framework that combines multiple mapping strategies to improve robustness across diverse clinical datasets ^[30]D5.

Infrastructure for Specialized Data Types

Functioning and Social Needs Data

Exchange of health-related social needs (HRSN) data and functioning data (ICF) requires additional infrastructure beyond standard clinical codes. In the US, 61.4% of hospitals reported electronically receiving HRSN data from external sources, most commonly from health information exchange organizations ^[39]B2c. Hospitals using Epic or Cerner EHRs were more likely to participate in HRSN exchange, highlighting how vendor capabilities shape infrastructure readiness ^[39]B2c. In Europe, many countries lack standardized EHR support for structured ICF data storage, and a three-phase roadmap has been proposed: (1) promoting ICF awareness and structured documentation, (2) advancing technical integration through FHIR and ontology development, and (3) aligning policy and governance to support scaling ^[22]D5.

Blockchain and Post-Quantum Security

Emerging architectures, such as consortium blockchain combined with the Extended Merkle Signature Scheme (XMSS), offer post-quantum security guarantees for healthcare data sharing. One proposed scheme reduces total computational overheads by approximately 49% and blockchain storage by 36% compared to alternative cryptographic approaches, while enabling autonomous AI-assisted diagnostic report generation ^[36]D5. Although not yet widespread, such architectures address the growing threat of quantum computing to conventional cryptographic mechanisms ^[36]D5.

Implementation Governance and Sustainability

Technical infrastructure alone does not guarantee interoperability success. A systematic review of learning health system (LHS) implementations identified that most initiatives lacked discussion of long-term economic sustainability models; only 16 of 37 papers provided objective measurements of performance changes ^[32]D5. Effective infrastructure requires national governance to establish common APIs, efficient ethical approval processes, and channels for sharing tacit knowledge across initiatives ^[32]D5. Furthermore, the success of HIE technology depends not only on the architecture but also on the active participation of multidisciplinary teams in decision-making ^[32]D5.

Controversies and Guideline Disagreement

Pearl: When designing an interoperability infrastructure, prioritize a vendor-agnostic API strategy that separates data from applications, this principle enables the same service (e.g., pharmacogenomic guidance, social needs data) to integrate with multiple EHRs without custom interfaces ^[37]D5. Pair the API with automated terminology mapping using complementary algorithms (NLP + semantic search) to handle the variable data quality found across real-world datasets ^[30]D5.

Building on the technical architectures described above, interoperability is not a binary state but exists across four distinct levels, each building on the one below. The Healthcare Information and Management Systems Society (HIMSS) model formalizes this progression from basic data transport to coordinated organizational exchange.

Foundational Interoperability

At the lowest level, foundational interoperability ensures that one system can send data to another and the receiving system can accept the transmission. It relies on standard network protocols (e.g., TCP/IP, HTTPS) and secure transport (e.g., TLS). No requirement exists for the receiver to interpret or structure the data in any particular way. A simple HL7 v2 message exchange is a common example. While foundational interoperability is essential for any data flow, it offers no guarantees about data meaning or usability - limitations that become apparent as more complex exchange is attempted ^[41]D5.

Structural Interoperability

Structural interoperability defines the format, syntax, and organization of the exchanged data so that the receiving system can parse and process the information at a field level. Standards such as HL7 v3, Clinical Document Architecture (CDA), and FHIR provide the structural frameworks. FHIR, in particular, has gained adoption because its resource-based model maps clinical concepts (Patient, Observation, MedicationRequest) into discrete, queryable elements. A systematic mapping review found that 31 of 126 (24.6%) proposed semantic approaches using FHIR focused on mapping legacy data to FHIR resources ^[42]D5. Structural interoperability ensures that a lab result is placed in the correct field, but it does not guarantee that the coded value (e.g., "123.4" in a "value" element) is understood identically by both systems.

Semantic Interoperability

Semantic interoperability is the level at which the meaning of the exchanged data is preserved and interpreted consistently by both sender and receiver. It requires shared clinical terminologies (SNOMED CT, LOINC, RxNorm), ontologies (e.g., ICD-10, CPT), and data models that encode meaning. A systematic review identified six semantic techniques critical to achieving this level: EHR standardization, controlled vocabularies, ontologies, semantic web technologies, knowledge graphs, and natural language processing (NLP) ^[41]D5. The same review mapped these techniques to 16 core data quality indicators and FAIR principles, highlighting that semantic interoperability improves data conformance, portability, usability, and applicability ^[41]D5. In a separate mapping of FHIR semantic studies, six categories of approaches emerged: mapping (24.6%), terminology services (14.3%), RDF/OWL proposals (19%), annotation (14.3%), ML/NLP (15.9%), and ontology-based proposals (11.9%) ^[42]D5.

Failure to achieve semantic interoperability undermines data harmonisation, which requires consistent terminology and unique patient identifiers across databases. A scoping review of data harmonisation identified nine key components, including pooling data using unique patient identifiers and harmonising different types of data across institutions ^[43]D5. Real-world evidence of the challenge comes from oncology: an analysis of 20,671 patients across five Saudi centers found only 62.43% overall alignment with the Minimal Common Oncology Data Elements (mCODE) standard and 49.02% data completeness, though accuracy was high at 95.03% ^[44]C4.

Organizational Interoperability

The highest level extends beyond technical and semantic concordance to encompass the governance, policies, workflows, and trust arrangements that enable seamless data exchange across healthcare enterprises. It includes shared agreements on data stewardship, consent management, liability, and clinical workflows. Blockchain-based self-sovereign identity systems have been proposed to support secure identity management and patient-controlled data access across organizations, though most remain at the prototype stage ^[4]B2a. Patient safety is directly affected: during the Epic Radiant go-live at Helsinki University Hospital, a cluster of serious incidents (11 radiology-related serious incidents post-go-live) were linked to integration gaps, insufficient end-to-end testing, and workflow strain - failures of organizational interoperability ^[8]B2b. Similarly, implementation of electronic patient-reported outcomes (ePROs) in oncology faces barriers at the system level, including interoperability deficits that impede data integration across platforms ^[15]D5. National readiness also varies: a scoping review of AI in Kazakhstan's healthcare identified gaps in training, governance, and interoperability as barriers to routine clinical implementation ^[40]D5.

These levels build upon each other; failures at any level contribute to the persistent challenges detailed in the next section.

Pearl: Interoperability is only as strong as its weakest level - a system that achieves semantic interoperability for structured lab results may still fail if organizational policies prevent data sharing across networks or if governance agreements are absent. Maturity models (such as HIMSS) provide a roadmap for progressive improvement.

As the preceding section outlined the graduated levels of interoperability, from foundational to semantic, the persistent disconnect between these theoretical tiers and real-world performance stems from a layered set of barriers that are simultaneously technical, organizational, and human ^[46]B2a. These obstacles can be organized into a three-level framework: macro-level (organizational and regulatory), meso-level (technical and clinical), and micro-level (human factors and training) ^[46]B2a.

Macro-Level Barriers: Organizational and Regulatory

Governance and compliance conflicts consistently impede cross-system data exchange ^{[19]B2a[46]B2a}. Blockchain-based EHR architectures, for example, create an irreconcilable tension between the immutability of distributed ledgers and regulatory requirements such as the GDPR "right to erasure" ^[19]B2a[1]D5. Similarly, country-specific applicability of HIPAA and GDPR introduces jurisdictional complexity that most health IT systems are not designed to navigate ^[19]B2a.

Limited digital health interoperability is a persistent challenge even in rapidly reforming health systems. The United Arab Emirates achieved a 16.8% annualized growth in Joint Commission International-accredited facilities (229 by February 2026, one of the highest outside the US) and widespread electronic medical record adoption (75% penetration in Dubai's private clinics), yet interoperability between Emirates and across sectors remained limited, one of the "persistent challenges" identified in a systematic review of UAE healthcare reforms from 2017 to 2024 ^[45]B2a. Regulatory burden was also cited as a common barrier to clinical decision support (CDSS) implementation in cardiovascular care, alongside organizational failure to provide leadership commitment and stakeholder engagement ^[46]B2a.

Meso-Level Barriers: Technical and Clinical

Data standardization remains fragmented despite decades of effort. Among 99 studies evaluating the three major health data standards, 57% used OMOP-CDM, 39% FHIR, and only 8% openEHR ^[20]B2a. Critically, 87% of applications occurred in research settings, not clinical practice ^[20]B2a. FHIR implementations frequently require customization to local contexts, which paradoxically undermines the interoperability the standard was designed to achieve ^[20]B2a. OMOP-CDM offers robust analytical tooling but creates challenges in mapping source variables and risks data loss; only 27% of studies reported the coverage (i.e., the number of mapped source variables) of the standard used ^[20]B2a. openEHR's uptake remains limited and its limitations poorly documented ^[20]B2a.

Poor interoperability across electronic health records also undermines risk prediction tools in primary care: a systematic umbrella review identified lack of integration with EHRs and poor interoperability as key barriers to implementing digital risk prediction models, alongside a need for codesign with clinicians and integration with digital infrastructure ^[47]B2a.

Data heterogeneity further compounds these issues. Traditional post-hoc standardization is costly, labor-intensive, and reduces data granularity ^[3]D5. A proposed hybrid strategy uses large language models to analyze unstructured legacy data while prospectively standardizing new data, offering an alternative to full harmonization, but acknowledging that LLMs lack precision for some tasks ^[3]D5.

Performance and scalability constraints are prominent in blockchain-based approaches, where latency versus throughput trade-offs during consensus remain unresolved ^[19]B2a[1]D5. Even when smart-contract-based recruitment shows rapid matching performance (6000 simulated patients matched in 2.13 seconds), these are non-production analyses with limited real-world validation ^[1]D5[19]B2a. In a scoping review of blockchain-enabled self-sovereign identity (BC-SSI) in healthcare, a structural gap emerged "between technological capability and system-level readiness for clinical deployment" ^[4]B2a. Persistent challenges include interoperability limitations, governance gaps, usability concerns, and insufficient integration with existing healthcare infrastructures ^[4]B2a.

Electronic problem lists (PLs), central to the problem-oriented medical record, remain incomplete, outdated, or inconsistently maintained, with persistent issues of unclear ownership, workflow misalignment, and variability in what constitutes a "problem" ^[2]B2a. Emerging technologies (CDS, NLP, machine learning) are increasingly used to support PL generation but deliver greatest benefit only when embedded within clinician-led workflows ^[2]B2a.

Micro-Level Barriers: Human Factors and Training

Workflow disruption and alert fatigue are among the most frequently reported barriers to CDSS adoption in cardiovascular care ^[46]B2a. Family physicians now spend approximately half their professional time on indirect patient care activities (IPCA) in the electronic inbox, renewing prescriptions, checking lab results, and reviewing messages, creating a system where "fragmented technical systems and an overwhelming volume of complex tasks" lead to excessive time on duplicated or unnecessary tasks, inadvertently uninformed clinical decisions, and perceived tension between patient accessibility and workload ^[11]B2a. This electronic inbox burden is linked to burnout and the family medicine crisis in Canada ^[11]B2a.

Lack of staff training is another consistent micro-level barrier ^[46]B2a. Even when technical solutions exist, clinicians cannot use them effectively without targeted training and workflow integration. Key facilitators for overcoming micro-level barriers include leadership commitment, stakeholder engagement, iterative tool refinement, and redesign of electronic medical record systems to reduce unnecessary inbox tasks ^{[11]B2a[46]B2a}.

The Socio-Technical Nature of Interoperability Barriers

A recurring theme across all three levels is that the most formidable barriers to interoperability are not purely technical but socio-technical. While the architectures of blockchain-based EHR systems could improve auditability, access control, and technical communication, particularly when integrated with standards such as HL7 FHIR, the existing literature is "very limited and primarily consists of non-production analyses" ^[19]B2a. A coordinated governance framework is needed that encompasses organizational commitment, technical integration, clinician involvement, patient engagement, and regulatory alignment, supported by ongoing training and capacity building ^[46]B2a. Addressing these interdependent barriers is the prerequisite for the implementation strategies discussed in the next section.

Pearl: The most persistent barrier to interoperability is not the absence of technology but the failure to align technical standards with clinical workflows and governance structures, a socio-technical challenge that no single standard or platform can solve without organizational commitment and human-centered design ^{[46]B2a[19]B2a}.

Despite well-documented barriers, healthcare organizations can achieve meaningful interoperability through deliberate governance, standards alignment, and workflow integration ^{[20]B2a[46]B2a}. The evidence points to a multi-level approach that addresses organizational, technical, and human factors simultaneously, rather than pursuing technology alone.

Governance and Leadership Commitment

Effective implementation begins with a coordinated governance framework that ensures organizational commitment, stakeholder engagement, and regulatory alignment ^[46]B2a. In the United Arab Emirates, the Abu Dhabi Healthcare Strategic Plan drove a 16.8% annualized growth in Joint Commission International-accredited facilities and 75% electronic medical record penetration in Dubai's private clinics, demonstrating the impact of top-down strategic planning ^[45]B2a. Key governance actions include:

• Establishing clear ownership for data quality and problem list accuracy, as incomplete or outdated problem lists undermine interoperability and clinical decision support ^[2]B2a
• Creating shared accountability across clinical, technical, and administrative teams ^{[2]B2a[46]B2a}
• Engaging clinicians and public in codesign from the outset to ensure tools meet real-world workflow needs ^[47]B2a

Standards Adoption and Hybrid Approaches

No single standard serves all use cases. A systematic review of FHIR, OMOP-CDM, and openEHR found that only 27% of studies reported coverage (the number of mapped source variables), and each standard has distinct strengths:

• FHIR is preferred for real-time data exchange and public health domains, though its implementations often require customization that can complicate interoperability ^[20]B2a
• OMOP-CDM offers strong analytical tooling for large-scale, longitudinal research but poses challenges for mapping and data loss ^[20]B2a
• openEHR supports data persistence, but its uptake remains limited ^[20]B2a

A hybrid approach that selects the appropriate standard for each use case, FHIR for exchange, OMOP-CDM for analytics, openEHR for persistence, is essential to build scalable, interoperable ecosystems ^[20]B2a. Integrating blockchain architectures with FHIR can further improve auditability and access control, though existing evidence is limited to prototype stages ^[19]B2a.

Workflow Integration and Clinician Engagement

Interoperability tools fail when they disrupt clinical workflows. Common barriers include alert fatigue, poor integration with existing systems, and lack of staff training ^[46]B2a. Successful implementations share three characteristics:

1. Iterative refinement with end-users: tools are co-designed, piloted, and adjusted based on feedback ^{[46]B2a[47]B2a}
2. Targeted clinician training: ongoing education tailored to specific roles and tasks ^[46]B2a
3. Bidirectional system integration: for example, connecting EHRs with smart infusion pumps reduced medication errors and improved charging accuracy, though evidence quality remains low due to observational designs ^[48]B2a

Electronic problem lists, foundational for interoperability and AI, are most effective when generated and curated within clinician-led workflows using natural language processing and machine learning support ^[2]B2a.

Data Quality and Semantic Harmonization

Poor data quality undermines all interoperability efforts. Implementations must map source variables to standard terminologies (e.g., SNOMED CT, LOINC) with explicit coverage reporting ^[20]B2a. Semantic harmonization remains a challenge, particularly in blockchain-based systems where partial FHIR coverage and varying term usage hinder exchange ^[19]B2a. Organizations should establish data governance policies that require minimum coverage thresholds and regular reconciliation ^{[2]B2a[20]B2a}.

Leveraging Emerging Technologies

Emerging technologies offer targeted solutions for persistent interoperability gaps:

• Blockchain smart contracts can automate clinical trial processes including patient matching (e.g., 6000 patients matched in 2.13 seconds), consent management , and audit logging, though deployment is limited to private Ethereum-based networks ^[1]D5
• Self-sovereign identity systems enable patient-controlled access via decentralized identifiers and verifiable credentials, but remain at early maturity with limited clinical integration ^[4]B2a
• AI and machine learning tools in rehabilitation and laboratory settings have improved workflow efficiency and diagnostic support, yet real-world implementation remains scarce, only 10 studies were identified across Kazakhstan's entire AI healthcare landscape ^[40]D5

Monitoring and Continuous Evaluation

Sustainability requires ongoing measurement of interoperability outcomes. Organizations should track exchange success rates, API response times, standards compliance, and, most importantly, clinical impact on workflow efficiency and patient safety ^{[19]B2a[48]B2a}. Regular audits of problem list accuracy and data coverage help maintain the trust that underpins effective data sharing ^[2]B2a.

Pearl: Early stakeholder engagement, phased standards adoption, and iterative workflow integration are higher-yield investments than any single technology, focus on governance and people before platforms ^{[20]B2a[46]B2a}.

Implementation strategies for EHR interoperability must operate within a complex and evolving regulatory landscape that both mandates and shapes data exchange. Policy frameworks in the United States, Europe, and other regions have established legal requirements, incentives, and standards that directly influence how health information flows across systems.

United States Policies: From Meaningful Use to the 21st Century Cures Act

US federal policy has progressively tied financial incentives to interoperability. The Meaningful Use program and subsequent value-based payment models link physician reimbursement to the use of electronic clinical quality measures (eCQMs) that rely on automated data capture from EHRs ^[50]D5. Standards such as the Quality Data Model enable structured data extraction, but lack of health system data interoperability and problems with measure accuracy persist ^[50]D5. The 21st Century Cures Act accelerated exchange through the Trust Exchange Framework and Common Agreement (TEFCA), which established the Individual Access Service, allowing patients to direct the flow of their own health data across organizations ^[9]D5. Despite these advances, family physicians report ideal interoperability experiences in only 8% to 19% of data types, with the lowest rates for test results from outside hospitals or health systems (8%) and encounter documents (19%) ^[51]C4. Interventions that increase automated data retrieval by 20 percentage points yield only a 1 percentage point improvement in ideal experiences, suggesting that policy mandates alone are insufficient ^[51]C4. Critical gaps also exist for vulnerable populations: physicians with panels of more than 50% vulnerable patients are significantly less likely to experience ideal interoperability for primary care notes and consultation reports (OR 0.66, 95%) ^[51]C4.

Policy must also address equity. The Americans With Disabilities Act and Section 1557 of the Affordable Care Act mandate accessibility in digital health, including standardized disability data collection in EHRs and enforcement of patient interoperability mandates ^[52]D5. Civil rights frameworks now treat inaccessible health IT as a compliance violation, with penalties for noncompliance ^[52]D5.

European Health Data Space and GDPR

The European Health Data Space (EHDS) regulation introduces a transformative framework for cross-border health data exchange among EU member states ^[22]D5. A key interoperability measure is the inclusion of the International Classification of Functioning, Disability and Health (ICF) as a standard for documenting functioning in patient summaries and discharge reports ^[22]D5. However, many countries lack standardized EHR support for structured ICF data, and low professional awareness hinders adoption ^[22]D5. To address disparities, a three-phase roadmap has been proposed: (1) promoting ICF awareness and structured documentation, (2) advancing technical integration through FHIR and ontology development, and (3) aligning policy and governance to support scaling ^[22]D5. These efforts must operate within GDPR requirements for data protection, which add complexity to cross-border exchange ^[22]D5.

Global Perspectives: UAE and UK

Outside the US and EU, other nations illustrate the interplay of policy and interoperability. The United Arab Emirates achieved rapid EHR adoption with 75% penetration in Dubai's private clinics, yet persistent challenges in digital health interoperability remain, alongside workforce gaps and inter-Emirate equity disparities ^[45]B2a. The United Kingdom 's National Health Service, the world's largest public healthcare system, has pursued nationwide EHR implementation but faces considerable hurdles in executing its vision due to interoperability standards that are not yet fully realized ^[49]D5. Both countries highlight that policy vision must be matched by investment in standards and security to enable seamless communication ^[49]D5.

Policy Challenges and Future Directions

Across all regulatory environments, policy alone cannot guarantee interoperability. The Veterans Health Administration's experience demonstrates that building infrastructure for patient-generated health data (PGHD) to FHIR standards, coupled with clinical dashboards and equity-focused research, can bridge policy intent and clinical reality ^[53]C4. Nonetheless, persistent interoperability gaps, particularly for vulnerable populations and across payers, require coordinated action on standards adoption, workforce training, and universal design principles ^[51]C4[52]D5. As jurisdictions from the EU to the UAE continue to refine their regulatory frameworks, the lesson is clear: policy must be paired with technical and human infrastructure to achieve the goal of seamless, equitable data exchange.

Pearl: Policy mandates such as the Cures Act and EHDS establish the legal foundation for interoperability, but the translation to clinical practice remains incomplete; achieving ideal data exchange requires simultaneous investment in standards adoption, workforce training, accessibility enforcement, and equity-focused design.

Building on the regulatory frameworks discussed above, practical security and privacy protections must be embedded at every layer of interoperable health-data exchange, because each additional access point expands the attack surface for breaches, unauthorized disclosures, and consent violations ^[56]D5. The challenge is not merely technical: legal, ethical, and human-centered strategies are equally necessary to maintain trust and compliance ^[56]D5.

Encryption and Data Protection

Encryption of data at rest and in transit is the minimum standard. Interoperable systems that transmit structured clinical data (e.g., HL7 FHIR resources) must employ transport-layer security (TLS 1.3) and encrypt stored records using AES-256 or equivalent. A scoping review of e-health technologies in primary care found that insufficient encryption and data breaches were among the most frequently reported concerns, particularly in decentralized and resource-limited settings ^[56]D5. Pseudonymisation offers an additional layer: the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) converts complex electronic medical record (EMR) data into a standardised format, allowing shared analysis packages to be executed across sites without direct patient-level data exchange (the data remain firewalled locally) ^[57]D5. This approach simultaneously enhances privacy and facilitates multi-institutional research ^[57]D5.

Authentication and Identity Management

Secure authentication is foundational to interoperability. Self-sovereign identity (SSI) models, enabled by blockchain technology, allow individuals to control their digital identity without reliance on a central authority ^[4]B2a. Blockchain-enabled SSI (BC-SSI) systems use decentralized identifiers (DIDs), verifiable credentials, and smart contracts to manage identity verification, credential issuance, and privacy-preserving data exchange ^[4]B2a. However, current BC-SSI research remains at an early maturity stage: most proposals are conceptual prototypes with limited real-world deployment, and persistent gaps exist in interoperability, governance, and integration with existing healthcare infrastructures ^[4]B2a. In clinical trials, blockchain-based smart contracts have demonstrated rapid patient matching (e.g., 6000 simulated patients matched in 2.13 seconds), yet all implementations remain non-production ^[1]D5.

Consent Management

Consent management becomes exponentially more complex when data cross institutional and jurisdictional boundaries. Dynamic consent, a model enabling granular, interactive, and revocable management of patient preferences, has emerged as a patient-centered alternative to static broad consent ^[6]D5. Under the European General Data Protection Regulation (GDPR) and the forthcoming European Health Data Space (EHDS) Regulation, dynamic consent must accommodate machine-readable consent artifacts, high-assurance digital identity (e.g., eIDAS 2.0), and policy-based enforcement ^[6]D5. A proposed three-stage operational architecture, consent administration, decision, and enforcement, aims to embed dynamic consent within hybrid regulatory frameworks ^[6]D5. Nevertheless, significant barriers remain: national fragmentation of lawful bases, limited cross-border revocation mechanisms, implementation costs, consent fatigue, and digital divides affecting vulnerable populations such as older adults and low-literacy groups ^[6]D5[56]D5.

Controversies and Guideline Disagreement

Blockchain-based systems offer superior auditability and tamper resistance, but the GDPR “right to erasure” directly conflicts with blockchain’s immutability; a systematic review noted that this tension, along with key management and governance gaps, remains unresolved in most prototypes ^[19]B2a. The EHDS introduces a parallel track: from 2029, many secondary uses will be authorized by Health Data Access Bodies rather than individual consent, reducing reliance on dynamic consent for large-scale population research ^[6]D5. Both paths require robust technical safeguards, including privacy-by-design principles, provider training, and user-centered design to ensure equitable digital health equity ^[56]D5.

Pearl: For interoperable systems handling cross-jurisdictional data, the safest strategy is to store identifiable information off-chain with a cryptographic link to an on-chain permission that can be revoked; dynamic consent artifacts (e.g., HL7 FHIR Consent resource) should be machine-readable and enforceable at the application layer.

Building on the security and privacy frameworks that underpin current interoperability, emerging technologies promise to extend the reach and intelligence of data exchange, though significant implementation challenges remain.

Blockchain and Distributed Ledger Technologies

Blockchain-based EHR systems can improve auditability, access control, and technical communication, particularly when integrated with standards such as HL7 FHIR ^[19]B2a. Smart contracts, self-executing code on distributed ledgers, offer a dynamic, immutable record of clinical trial processes, including automated patient matching (6000 simulated patients matched in 2.13 s), consent management with dynamic permissioning, protocol enforcement, and time-stamped adverse event reporting ^[1]D5. Most implementations rely on private Ethereum networks (70% of studies) ^[1]D5.

Despite this promise, the literature remains tentative and limited to non-production pilots ^[19]B2a. Persistent barriers include:

• Performance and scalability constraints (latency vs. throughput trade-offs during consensus)
• Governance and compliance conflicts, e.g., GDPR's “right to erasure” versus blockchain immutability; country-specific application of HIPAA/GDPR
• Key management and identity life-cycle issues
• Data quality and semantic harmonization problems (partial coverage of HL7 FHIR, varying use of terms) ^[19]B2a

Blockchain-enabled self-sovereign identity (BC-SSI) offers decentralized identity management using verifiable credentials, zero-knowledge proofs, and selective disclosure. However, most BC-SSI research remains conceptual or prototype stage, with a structural gap between technological capability and system-level readiness for clinical deployment ^[4]B2a.

Artificial Intelligence and Machine Learning

AI/ML technologies are increasingly used to support problem list generation, curation, reconciliation, and organization, with greatest benefit when embedded within clinician-led workflows ^[2]B2a. Natural language processing and machine learning can help address the persistent challenge of incomplete or outdated problem lists, which are foundational for clinical decision support and interoperability ^[2]B2a.

Digital risk prediction tools in primary care face 15 identified barriers, including poor integration with EHRs and limited interoperability ^[47]B2a. A stakeholder consensus developed 14 core features for successful implementation, emphasizing early codesign with clinicians and the public, and integration with digital infrastructure and workflows ^[47]B2a.

International experience, such as in Kazakhstan, shows that AI readiness is hindered by limited workforce preparedness, insufficient formal training, and gaps in data protection and ethical regulation ^[40]D5. Real-world AI implementation remains limited to a small number of clinical settings (e.g., rehabilitation, laboratory medicine), where tools improved workflow efficiency and diagnostic support but lacked clinical validation ^[40]D5.

Bidirectional Interoperability with Smart Infusion Pumps

Bidirectional interoperability between EHRs and smart infusion pumps is a novel but geographically concentrated research area (all 7 included studies from the USA) ^[48]B2a. Observed effects were mainly positive: reduced medication errors, improved system compliance and workflow efficiency, and enhanced charging accuracy ^[48]B2a. However, evidence quality is low due to the observational nature of studies; future work should prioritize controlled designs and economic evaluations ^[48]B2a.

Automated Data Extraction for Registries and Risk Prediction

Technologies enabling automated data extraction from EHRs to clinical registries have been evaluated across 12 countries. Most approaches extract data from structured formats (n = 18) or a combination of structured and unstructured data (n = 10) ^[5]B2a. Epic was the most common EHR system; registries commonly used REDCap, SQL Server, or EMR-embedded solutions ^[5]B2a. These advances reduce manual data entry and enhance the use of real-world clinical data, supporting sustainable interoperability between EHRs and registries ^[5]B2a.

Summary of Emerging Technologies

These technologies are rapidly evolving, but their safe, effective adoption hinges on well-defined governance frameworks, cross-jurisdictional compliance, and rigorous clinical validation, themes that will be examined through global implementation experiences in the following section.

Pearl: When evaluating emerging interoperability technologies, prioritize demonstrated integration with EHR workflows and existing standards (e.g., HL7 FHIR) over technical novelty, the field's primary bottleneck is system-level readiness, not computational capability, as shown by the gap between blockchain prototypes and clinical deployment ^{[4]B2a[19]B2a}.

Building on the technological frontier described above, the real-world adoption of EHR interoperability reveals profound geographic disparities shaped by regulation, infrastructure, and funding. No single model has proven universally superior; instead, successful implementations are tightly coupled to local policy environments, workforce readiness, and alignment of incentives across payers, providers, and vendors.

Global Variation in Interoperability Maturity

Maturity ranges from fully mandated national frameworks to fragmented, facility-level systems. The European Health Data Space (EHDS) regulation represents the most ambitious legislative push, requiring member states to adopt the International Classification of Functioning, Disability and Health (ICF) as a standard for documenting functioning in patient summaries and discharge reports ^[22]D5. However, a 2026 review found that most EU countries lack standardized EHR support for structured ICF data storage, and low professional awareness further hinders data availability ^[22]D5. A proposed three-phase roadmap, promoting ICF awareness, advancing FHIR-based technical integration, and aligning policy and governance, aims to close these gaps by 2030 ^[22]D5.

In contrast, the United Arab Emirates has achieved rapid digital health expansion through centralized strategic planning. Since 2014, the Abu Dhabi Healthcare Strategic Plan has driven 16.8% annualized growth in Joint Commission International-accredited facilities, reaching 229 by February 2026, one of the highest concentrations outside the United States ^[45]B2a. 75% of Dubai's private clinics now use electronic medical records, yet the same review identifies limited digital health interoperability and equity disparities between Emirates as persistent barriers ^[45]B2a.

Case Study: European Health Data Space and ICF Integration

The EHDS provides a natural experiment in legislated interoperability. By requiring ICF alongside ICD and other terminologies, the regulation forces semantic harmonization of functioning data, a domain historically excluded from structured exchange ^[22]D5. The review notes that without mapping ICF to established health informatics frameworks such as HL7 FHIR, semantic interoperability remains aspirational ^[22]D5. Countries like Finland and the Netherlands have pilot ICF-FHIR mappings, but scalable production use is still years away ^[22]D5. The EHDS model demonstrates that policy mandates can accelerate adoption, but only when accompanied by technical infrastructure investment and clinician training.

Case Study: UAE Healthcare Reform and Digital Health

The UAE experience highlights the tension between volume and quality of digitization. Despite widespread EHR penetration, interoperability was flagged as a critical weakness in the 2017-2024 systematic review ^[45]B2a. The country's antimicrobial stewardship program achieved an 81.7% cost reduction and 40% reduction in hospital stays through integrated electronic systems, but these gains are largely confined to tertiary hospitals in Abu Dhabi and Dubai ^[45]B2a. Smaller Emirates and primary care settings lag, creating a two-tier digital health system. The lesson: nationwide adoption of EHRs does not guarantee cross-facility data exchange; dedicated interoperability governance is required.

Case Study: Electronic Medicines Management in Developing Countries

A 2025 landscape review identified 314 records describing electronic medicines management systems (EMMS) across 45 developing countries, predominantly in secondary care, operating locally rather than regionally or nationally ^[58]B2a. Common use cases include adherence monitoring in HIV and tuberculosis treatment, where EMMS integration with broader EHRs is often partial ^[58]B2a. Only 206 of 314 records described coexistence or integration of EMMS with other health data such as EHRs, suggesting that many systems function as silos ^[58]B2a. The review emphasizes that expanding interoperability and scale of EMMS could enable transformative digital technologies, increasing efficiencies and coverage ^[58]B2a. The barrier is not technological but economic: low-resource settings lack the capital for enterprise-level integration and sustainable maintenance contracts.

Lessons from Digital Health Growth-Stage Companies

A systematic review of 36 successful digital health companies found system interoperability to be a statistically significant success factor for digital health technology (DHT) companies compared with general digital companies ^[54]D5. Financial viability (cited in 18 studies) and regulatory alignment (15 studies) were the most frequently reported factors overall ^[54]D5. The failure of once-promising companies like Pear Therapeutics and Proteus Digital Health, both declaring bankruptcy after initial breakthroughs, underscores that interoperability with existing EHR workflows is a prerequisite for scaling, not a nice-to-have feature ^[54]D5. In contrast, companies that embedded FHIR-native architectures and aligned with national interoperability mandates (e.g., US 21st Century Cures Act) achieved more sustainable growth ^[54]D5.

Emerging Models: Blockchain and Common Data Models

Pilot implementations of blockchain for EHR exchange show improvements in security and technical interoperability, but the evidence is limited to 16 empirical studies, primarily prototypes and pilots ^[19]B2a. Key issues include performance and scalability constraints (latency vs. throughput trade-offs), governance conflicts (GDPR right to erasure vs. immutable ledgers), and semantic harmonization gaps (partial coverage of HL7 FHIR) ^[19]B2a. On the data-modeling front, the OMOP Common Data Model (CDM) and HL7 FHIR scored highest across suitability, popularity, and interoperability criteria in a 2025 systematic evaluation, but no single CDM or standard can serve all use cases ^[21]B2a. The recommended approach is to enable transformation between representations within a single tool ^[21]B2a.

Pearl: Interoperability success depends less on any single technology and more on national policy mandates, workforce readiness, and sustained investment in standards alignment, the UAE’s digitization without cross-system exchange and the EU’s ambitious ICF mandate without ready infrastructure both illustrate that technical solutions must be matched by governance and training.